Real-time enrollment status for this malignant brain neoplasm clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 11:18 PM UTC
| NCT Number | NCT03649880 |
| Recruiting Status | Recruiting |
| Condition | Malignant Brain Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 77 participants |
| Active Locations | 1 sites in the US |
| Sponsor | OHSU Knight Cancer Institute |
| Last Updated on CT.gov | September 18, 2026 (Sep 18, 2026) |
As of October 19, 2026: Clinical trial NCT03649880 is currently recruiting participants. This phase2 study for malignant brain neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by OHSU Knight Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03649880 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03649880 was last updated Sep 18, 2026 (September 18, 2026). HelloStudys verifies this status automatically.